EUVIMEDScopri EUVIMED
Kohortenstudie

Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021

Michael H Le, Joanne K Liu, KeeSeok Lee, Ramsey Cheung, Mindie H Nguyen iD

Alimentary Pharmacology & Therapeutics · 2025-08 · 62 (3) · 340-348

DOI: 10.1111/apt.70193 ↗

At a glance

Kohortenstudie in Alimentary Pharmacology & Therapeutics, published online on 2025-05-26. Written by Michael H Le and 4 co-authors. Institution: Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA. Major MEDLINE topics: Hepatitis B, Chronic, Delayed Diagnosis. Cited 4 times so far (Crossref); 23 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Underdiagnosis of chronic hepatitis B (CHB) remains a major problem in the United States (USA), with > 80% of CHB patients remaining undiagnosed.

Aims

To determine the prevalence of late diagnosis of CHB and resultant liver complications.

Methods

This retrospective analysis of the Truven MarketScan database (1/2007–12/2021) included more than 250 million privately insured persons. The index date was the date of the first liver complication (cirrhosis, hepatocellular carcinoma [HCC], or liver transplant). Late diagnosis was defined as the diagnosis of CHB 2 years prior to or after the index date. Adults aged ≥ 18 years with a diagnosis of CHB and ≥ 12 months of insurance coverage prior to the index date were included. Exclusion criteria included > 90 days break of insurance coverage within 12 months before the index date and receipt of nonliver transplant within 5 years of the index date.

Results

2608 persons met inclusion criteria with a mean age of 54.8 years and 70.3% were male. 1999 (76.6%) had a late diagnosis of CHB, of whom 889 (44.5%) were diagnosed at or within 6 months of the index complication, and 1510 (75.5%) did not have a documented visit with a provider to the index date. Late diagnosis rate remained stable between 2009 (73.8%) and 2017 (74.2%, p‐trend = 0.937 ) . In the late diagnosis group, complications included cirrhosis ( n = 1820, 91.0%), decompensated cirrhosis ( n = 1630, 81.5%), HCC ( n = 615, 30.8%) and liver transplant ( n = 288, 14.4%).

Conclusion

Approximately three‐fourths of patients diagnosed with CHB in the USA had a late diagnosis. Increased screening efforts must be made to prevent poor clinical outcomes.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicDelayed DiagnosisHumansMaleFemaleRetrospective StudiesMiddle AgedUnited StatesAdultAgedCarcinoma, HepatocellularLiver NeoplasmsPrevalenceCohort StudiesYoung AdultLiver Cirrhosis

Author keywords

diagnosishepatitis Bpericomplicationscreening

Authors and institutions

  • Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
  • The Robert Larner MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
  • Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, California, USA.
  • Department of Epidemiology and Population Health, Stanford School of Medicine, Stanford, California, USA.

ORCID profiles: Mindie H Nguyen

Cite

APA

Le, M. H., Liu, J. K., Lee, K., Cheung, R., & Nguyen, M. H. (2025). Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021. Alimentary Pharmacology & Therapeutics, 62(3), 340-348. https://doi.org/10.1111/apt.70193

Vancouver

Le MH, Liu JK, Lee K, Cheung R, Nguyen MH. Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021. Alimentary Pharmacology & Therapeutics. 2025;62(3):340-348. doi:10.1111/apt.70193

BibTeX
@article{Le2025,
  author = {Le, Michael H and Liu, Joanne K and Lee, KeeSeok and Cheung, Ramsey and Nguyen, Mindie H},
  title = {Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {62},
  number = {3},
  pages = {340--348},
  doi = {10.1111/apt.70193}
}
Start for free →